Podcast with Alexander Nuyken on digital health and healthcare transformation

The healthcare system is on the brink of collapse , not from disease but from cost. Alexander Nuyken, EY's Life Science Strategy Leader, explains how digital health is forcing an unprecedented collaboration between doctors, tech companies, hospitals, and patients, and why the stakeholders who resist this transformation will be the ones who disappear. Subscribe for more episodes on how collaboration reshapes industries. In this second conversation, Alexander Nuyken shifts from financial transactions to the digital transformation of healthcare , a domain where collaboration is not optional but existential. The current system of brick-and-mortar hospitals, in-person diagnostics, and fragmented patient data is economically unsustainable. Digital health offers a path forward, but only if radically different stakeholders learn to work together. Nuyken identifies three areas where digital health creates transformative value. First, data aggregation: the massive amounts of health data generated daily in hospitals and through patient activities are almost entirely lost. When aggregated across millions of patients, this data reveals patterns in disease development, treatment efficacy, and risk factors that individual doctor-patient interactions cannot capture. The diabetes example illustrates how correlating eating behavior with disease outcomes could enable preventive intervention at a stage when lifestyle changes still matter. Second, remote monitoring: keeping patients in their homes rather than warehousing them in expensive hospital infrastructure reduces costs while improving quality of life. Continuous monitoring of rehabilitation progress, disease trajectory, and vital signs can be conducted remotely, freeing hospital capacity for cases that genuinely require it. Third, diagnostic collaboration at global scale: connected telehealth solutions enable patients to consult the best experts anywhere in the world. Algorithms can handle the 995 out of 1,000 standard test interpretations, routing only the genuinely complex cases to human specialists , who might be in China, Finland, or the United States. The conversation addresses the resistance this transformation generates. Doctors face a dual threat: potential redundancy as AI handles routine diagnostics, and challenges to professional self-image when machine predictions contradict clinical judgment. Nuyken argues that doctors who view AI as a partner rather than a threat will be the ones who succeed , using technology to focus on complex cases while routine work is handled cost-efficiently. The collaboration challenge is structural. Healthcare involves an unusually complex stakeholder landscape: patients, doctors, hospitals, insurance companies, pharmaceutical firms, technology providers, and regulators , each with different incentives, timelines, and definitions of success. Digital health requires all of them to share data, align standards, and accept that their traditional roles will change fundamentally. On the question of impact, Nuyken is confident: digital health is already extending life expectancy through prevention, early monitoring, and better-informed treatment decisions. The trajectory is clear, even if the precise numbers are not yet measurable. Part of the Ernst Strüngmann Forum series on Collaboration, produced with the Convergent Science Network.